RafaelSantana DavilaMD

PubMed

• 198 citations
  Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Pha...
  Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana-Davila, Neal Ready
  Clinical Cancer Research. 2019-12-01
• 108 citations
  A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.
  Cristina P. Rodriguez, Qian Vicky Wu, Jenna M. Voutsinas, Jonathan R. Fromm, Xiuyun Jiang
  Clinical Cancer Research. 2020-02-15
• 7 citations
  Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.
  Bruna Pellini Ferreira, Mary W. Redman, Kelsey Baker, Renato G. Martins, Keith D. Eaton
  The Laryngoscope. 2017-07-01

Journal Articles

• Evaluation and management of elderly patients with lung cancer.  
  Gore E, Movsas B, Santana-Davila R, Langer C, Semin Radiat Oncol, 1/1/2012
• Treatment options for patients with triple-negative breast cancer.  
  Santana-Davila, R. & Perez, E.A., J Hematol Oncol, 1/1/2010
• Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.  
  Jatoi, A., Smith EL, Gunderson, HD, Hartgers, ML, Looker SA, Santana-Davila R, McWilliams RR, J Oncol Pract, 1/1/2010
• Rearrangements and Amplification of IER3 2 (IEX-1) Represent A Novel And Recurrent Molecular Abnormality In Myelodysplastic Syndromes (MDS).  
  Steensma DP, Neiger JD, Porcher JC, Keats JJ, Bergsagel PF, Dennis TR, Knudson RA, Santana-Davila R, Kumar R, Ketterling RP, Cancer Res, 1/1/2009
• Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q.  
  Chen D, Hoyer JD, Ketterling RP, Tefferi A, Steensma DP, Holtan SG, Santana-Davila R, Porrata LF, Dewald GW and Hanson CA, Leukemia, 1/1/2009
• Genetic aberrations and survival in plasma cell leukemia.  
  Tiedemann RE, Gonzalez-Paz N, Kyle RA, Santana-Davila R, Price-Troska T, Van Wier SA, Chng WJ, Ketterling RP, Gertz MA, Henderson K, Greipp PR, Dispenzieri A, Lacy MQ,..., Leukemia, 1/1/2008
• Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): Clinicopathologic comparison of del(5q)-positive and -negative cases.  
  Santana-Davila R, Tefferi A, Holtan SG, Ketterling RP, Dewald GW, Knudson RA, Steensma DP, Chen D, Hoyer JD, Hanson CA, Leuk Res, 1/1/2008
• Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.  
  Santana-Davila R, Holtan SG, Dewald GW, Ketterling RP, Knudson RA, Hanson CA, Steensma DP, Tefferi A, Leuk Res, 1/1/2008
• Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era.  
  Holtan SG, Santana-Davila R, Dewald GW, Khetterling RP, Knudson RA, Hoyer JD, Chen D, Hanson CA, Porrata L, Tefferi A, Steensma DP, Am J Hematol, 1/1/2008
• Ploidy status rarely changes in myeloma patients at disease progression.  
  Chng WJ, Winkler JM, Greipp PR, Jalal SM, Bergsagel PL, Chesi M, Trendle MC, Ahmann GJ, Henderson K, Blood E, Oken MM, Hulbert A, Van Wier SA, Santana-Davila R, Kyle R..., Leuk Res, 1/1/2006
• Prognostic factors for hyperdiploid-myelom: effects of chromosome 13 deletions and IgH translocations.  
  Chng WJ, Santana-Davila R, Van Wier SA, Ahmann GJ, Jalal SM, Bergsagel PL, Chesi M, Trendle MC, Jacobus S, Blood E, Oken MM, Henderson K, Kyle RA, Gertz MA, Lacy MQ, D..., Leukemia, 1/1/2006
• Clinical implication of centrosome amplification in plasma cell neoplasm.  
  Chng WJ, Ahmann GJ, Henderson K, Santana-Davila R, Greipp PR, Gertz MA, Lacy MQ, Dispenzieri A, Kumar S, Rajkumar SV, Lust JA, Kyle RA, Zeldenrust SR, Hayman SR, Fonse..., Blood, 1/1/2006
• FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.  
  Chng WJ, Van Wier SA, Ahmann GJ, Winkler JM, Jalal SM, Bergsagel PL, Chesi M, Trendle MC, Oken MM, Blood E, Henderson K, Santana-Davila R, Kyle RA, Gertz MA, Lacy MQ, ..., Blood, 1/1/2005
• Quality of medical education in Mexico.  
  Santana-Davila R, Martinez C, Lancet, 1/1/2004
• The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.  
  Fonseca R, Debes-Marun CS, Picken EB, Dewald GW, Bryant SC, Winkler JM, Blood E, Oken MM, Santana-Davila R, Gonzalez-Paz N, Kyle RA, Gertz MA, Dispenzieri A, Lacy MQ, ..., Blood, 1/1/2003
• Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.  
  Debes-Marun CS, Dewald GW, Bryant S, Picken E, Santana-Davila R, Gonzalez-Paz N, Winkler JM, Kyle RA, Gertz MA, Witzig TE, Dispenzieri A, Lacy MQ, Rajkumar SV, Lust JA..., Leukemia, 1/1/2003
• Join now to see all

Lectures

• Clinicopathological characteristics of subsequent breast cancers in patients with benign breast disease. 
  45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL - 1/1/2009
• Deletion 5q in Acute Myeloid Leukemia (AML): a Clinicopathological Description of 79 Cases From a Single Institution. 
  50th Annual Meeting of the American Society of Hematology, San Francisco, CA - 1/1/2008
• Deletion 5q in WHO- Defined Myeloproliferative Neoplasms: A Clinicopathological Description 
  49th Annual Meeting of the American Society of Hematology, Atlanta, GA - 1/1/2007
• Trisomy 13 in Hematological Malignancies" 
  43rd Annual Meeting of the American Society of Clinical Oncology, Chicago, IL - 1/1/2007
• "Polymorphisms Associated with Clinical Outcome in the Intergroup Trial S9321, Comparing High Dose Therapy with Standard Dose Therapy for Myeloma on, on Behalf of ECOG... 
  46th Annual Meeting of the American Society of Hematology, San Diego, CA - 1/1/2004
• "Hamartoma of the pulmonic valve, a rare type of primary cardiac tumour" 
  American College of Physicians, Minnesota Chapter, Brooklyn Park, MN - 1/1/2003
• "High Incidence of p53 Deletion in Plasma Cell Leukemia (PCL), and Multiple Myeloma (MM) with Leukemic Transformation (MMLT)" 
  45th Annual Meeting of the American Society of Hematology, San Diego CA - 1/1/2003
• Join now to see all